Health product recall

M-Eslon Capsule: Product mix-up

Brand(s)
Last updated

Summary

Product
M-Eslon capsule
Issue
Health products - Labelling
What to do

Check your M-Eslon (morphine sulfate) medication bottle or package. If your prescription is for 30 mg capsules and the bottle contains 60 mg capsules, or if you are unsure, do not take these capsules and return them to your pharmacy. If you or someone you are caring for is experiencing an overdose (symptoms are described below), call 911 immediately and seek immediate medical attention

Affected products

Brand

Product Name

Market Authorization

Dosage Form

Strength

Lot numbers

Ethypharm Inc.

M-Eslon 30 mg capsule

DIN 02019949

Capsule (Extended release)

Morphine sulfate 30 mg

43885

Ethypharm Inc.

M-Elson 60 mg capsule

DIN 02019957

Capsule (Extended release)

Morphine sulfate 60 mg

43885

Issue

Affected lot may be labeled as M-Eslon 30 mg but may actually contain 60 mg capsules.

What you should do

  • Check your M-Eslon (morphine sulfate) medication bottle or package. If your prescription is for 30 mg, the capsules should be pink and clear. If it contains 60 mg capsules (orange and clear), or if you are unsure, do not take these capsules and contact your pharmacy immediately. Your pharmacist will check the capsules and provide you with a replacement if needed. Return the affected product to your pharmacy for proper disposal.
  • Call 911 immediately and seek immediate medical attention if you or someone you are caring for is experiencing an overdose (e.g., slow breathing, drowsiness, or difficulties waking up).
  • If an overdose is suspected, administer naloxone nasal spray or injection without delay. Give a repeat dose after 2 to 3 minutes if the person has not woken up or their breathing has not improved.
  • Contact your health care professional if you have taken the wrong dose of your medication and have any health concerns.
  • If you have questions about this recall contact Ethypharm Inc. by calling 1-855-694-0151, or by emailing customerservice@valeopharma.com.
  • Report any health product-related side effectsor complaints to Health Canada.

Additional information

Background

Depth of recall: Retailers

Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies

Recalling firm:

Valeo Pharma

16667 Hymus Blvd, 

Kirkland, Québec, H9H 4R9

Market authorization holder:

Ethypharm Inc

1200 Avenue McGill College, Suite 1500, 

Montréal, Québec, H3B 4G7

Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type I
Identification number
RA-76224
Media and public enquiries

Media Enquiries:

Health Canada

(613) 957-2983

media@hc-sc.gc.ca

Public Enquiries:

(613) 957-2991

1-866 225-0709

info@hc-sc.gc.ca

Get notified

Receive notifications for new and updated recalls and alerts by category.

Subscribe